share_log

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

拜切(納斯達克:BCPC)的資本回報率已經停滯。
Simply Wall St ·  10/29 18:54

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. With that in mind, the ROCE of Balchem (NASDAQ:BCPC) looks decent, right now, so lets see what the trend of returns can tell us.

我們應該關注哪些早期趨勢,以確定一個股票在長期內可能會成倍增值呢?首先,我們希望看到資本利用回報率(ROCE)在增加,其次是不斷擴大的資本利用基礎。如果您看到這一點,通常意味着這是一家擁有出色商業模式和豐富的盈利再投資機會的公司。考慮到這一點,拜切(納斯達克:BCPC)的ROCE看起來不錯,所以讓我們看看回報趨勢能告訴我們什麼。

What Is Return On Capital Employed (ROCE)?

我們對 Enphase Energy 的資本僱用回報率的看法:正如我們上面看到的,Enphase Energy 的資本回報率沒有提高,但它正在重新投資於業務。投資者必須認爲未來會有更好的前景,因爲股票表現良好,使持股五年以上的股東獲得了 690% 的收益。最終,如果基本趨勢持續存在,我們不會對它成爲一隻多頭股持有期很久很有信心。

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Balchem, this is the formula:

對於那些不確定什麼是ROCE的人,ROCE衡量公司從其業務中投入的資本中能夠產生多少稅前利潤。要爲拜切計算這個指標,這是公式:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。

0.11 = US$164m ÷ (US$1.6b - US$109m) (Based on the trailing twelve months to September 2024).

0.11 = 16400萬美元 ÷(16億美元 - 1.09億美元)(截至2024年9月的過去十二個月)。

Thus, Balchem has an ROCE of 11%. On its own, that's a standard return, however it's much better than the 8.6% generated by the Chemicals industry.

因此,拜切的ROCE爲11%。單獨看來,這是一種標準回報,但比化學品行業的8.6%要好得多。

big
NasdaqGS:BCPC Return on Capital Employed October 29th 2024
NasdaqGS:BCPC 2024年10月29日資本僱用回報率

Above you can see how the current ROCE for Balchem compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Balchem .

您可以看到拜切當前的ROCE與其以往資本回報相比,但過去的數據只能告訴我們這麼多。如果您感興趣,您可以在我們免費的拜切分析師報告中查看分析師的預測。

How Are Returns Trending?

綜合上述,Cimpress非常有效地提高了其資本利用率所產生的回報。考慮到股票過去五年保持穩定,如果其他指標也不錯,則可能存在機會。因此,進一步研究這家公司並確定這些趨勢是否會持續是合理的。

The trend of ROCE doesn't stand out much, but returns on a whole are decent. Over the past five years, ROCE has remained relatively flat at around 11% and the business has deployed 45% more capital into its operations. 11% is a pretty standard return, and it provides some comfort knowing that Balchem has consistently earned this amount. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

ROCE的趨勢並不突出,但總體回報還是不錯的。過去五年,ROCE保持在約11%左右相對平穩,企業將資本投入運營增加了45%。11%是相當標準的回報,它讓人放心地知道拜切一直能穩定地賺取這個數額。長時間來看,這樣的回報可能不會太令人興奮,但通過持續性,它們可以在股價回報方面得到回報。

The Bottom Line

還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。

To sum it up, Balchem has simply been reinvesting capital steadily, at those decent rates of return. And since the stock has risen strongly over the last five years, it appears the market might expect this trend to continue. So while the positive underlying trends may be accounted for by investors, we still think this stock is worth looking into further.

總的來說,拜切一直在以相對不錯的回報率穩定地再投資資本。由於過去五年股價大幅上漲,市場似乎預計這種趨勢會繼續。因此,雖然積極的潛在趨勢可能已被投資者考慮在內,但我們仍認爲這支股票值得進一步研究。

While Balchem doesn't shine too bright in this respect, it's still worth seeing if the company is trading at attractive prices. You can find that out with our FREE intrinsic value estimation for BCPC on our platform.

雖然在這方面拜切表現不太出色,但值得看看公司是否以有吸引力的價格交易。您可以通過我們平台上對BCPC的免費內在價值估算來了解這一點。

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

如果您想尋找財務狀況良好、回報卓越的實力強企業,可以免費查看以下公司列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論